noom glp-1 companion program Noom: Lose weight and keep it off Introducing Noom's free GLP-1 Companion

Your provider may order tests such as: Fasting glucose Fasting insulin or HOMA-IR (to assess insulin resistance) Hemoglobin A1C (for long-term blood sugar control) Lipid panel (cholesterol and triglycerides) Liver enzymes This step ensures that your baseline metabolic status is well understood and that any improvements after starting a GLP-1 can be accurately attributed to the new medication, rather than to changes in thyroid therapy

Your emergency surgical team will manage this

Starting at the lowest dose on the day of injection and the day after helps manage the peak side effect window

GLP-1 analogues market size was exhibited at USD 18.61 billion in 2025 and is projected to be worth around USD 304.09 billion by 2035, growing at a CAGR of 32.23% from 2026 to 2036